Our study analyzed 83 CRC patient tumor tissues from the National Cancer Institute (NCI) database, examining microsatellite instability (MSI), BRAF, KRAS/NRAS mutations, and neoplastic cell percentage. The gene discussed is KRAS; the disease is colorectal carcinoma.